Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves

Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves

In this retrospective comparative study, we evaluated the effectiveness of remdesivir (RDSV) in patients with SARS-CoV-2 pneumonia. Individuals hospitalized between March 2020 and August 2022 at S.M. Goretti Hospital, Latina, with a positive test for SARS-CoV-2 and, concomitantly, pneumonia, were in...

Full description

Bibliographic Details
Main Authors: Raffaella Marocco, Cosmo Del Borgo, Eeva Tortellini, Silvia Garattini, Anna Carraro, Daniela Di Trento, Andrea Gasperin, Alessandra Grimaldi, Tiziana Tieghi, Valeria Belvisi, Blerta Kertusha, Mariasilvia Guardiani, Paola Zuccalà, Danilo Alunni Fegatelli, Alessandra Spagnoli, Miriam Lichtner, LATINA COVID-group
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Viruses
Subjects:
remdesivir
SARS-CoV-2
antiviral therapy
COVID-19
real-life study
Online Access:https://www.mdpi.com/1999-4915/15/4/947

Internet

https://www.mdpi.com/1999-4915/15/4/947

Similar Items